Titre : Myopathie à axe central

Myopathie à axe central : Questions médicales fréquentes

Termes MeSH sélectionnés :

Behavior Therapy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Myopathie à axe central : Questions médicales les plus fréquentes", "headline": "Myopathie à axe central : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Myopathie à axe central : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-04", "dateModified": "2025-03-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Myopathie à axe central" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Myopathies congénitales structurales", "url": "https://questionsmedicales.fr/mesh/D020914", "about": { "@type": "MedicalCondition", "name": "Myopathies congénitales structurales", "code": { "@type": "MedicalCode", "code": "D020914", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.668.491.550" } } }, "about": { "@type": "MedicalCondition", "name": "Myopathie à axe central", "alternateName": "Myopathy, Central Core", "code": { "@type": "MedicalCode", "code": "D020512", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "David Lacomis", "url": "https://questionsmedicales.fr/author/David%20Lacomis", "affiliation": { "@type": "Organization", "name": "Departments of Neurology and Pathology (Neuropathology), University of Pittsburgh School of Medicine, Pittsburgh, PA." } }, { "@type": "Person", "name": "Ichizo Nishino", "url": "https://questionsmedicales.fr/author/Ichizo%20Nishino", "affiliation": { "@type": "Organization", "name": "Department of Neuromuscular Research, National Center of Neurology and Psychiatry (NCNP), National Institute of Neuroscience, 4-1-1 Ogawahigashi, Tokyo 187-8502, Japan; Medical Genome Center, NCNP, Tokyo, Kodaira, Japan. Electronic address: nishino@ncnp.go.jp." } }, { "@type": "Person", "name": "John Rendu", "url": "https://questionsmedicales.fr/author/John%20Rendu", "affiliation": { "@type": "Organization", "name": "INSERM, GIN-U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, University Grenoble Alpes, Bat EJ Safra, Chemin Fortuné Ferrini, La Tronche, Grenoble, France." } }, { "@type": "Person", "name": "Julien Fauré", "url": "https://questionsmedicales.fr/author/Julien%20Faur%C3%A9", "affiliation": { "@type": "Organization", "name": "INSERM, GIN-U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, University Grenoble Alpes, Bat EJ Safra, Chemin Fortuné Ferrini, La Tronche, Grenoble, France." } }, { "@type": "Person", "name": "Satoru Noguchi", "url": "https://questionsmedicales.fr/author/Satoru%20Noguchi", "affiliation": { "@type": "Organization", "name": "Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 187-8502 Tokyo, Japan; Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry, 187-8551 Tokyo, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Brief Behavioral Therapy for Anxiety and Depression in Pediatric Primary Care: Breadth of Intervention Impact.", "datePublished": "2022-08-24", "url": "https://questionsmedicales.fr/article/36030033", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaac.2022.08.007" } }, { "@type": "ScholarlyArticle", "name": "Drug use and suicidal ideation in the daily lives of individuals in a dialectical behavior therapy program.", "datePublished": "2023-07-18", "url": "https://questionsmedicales.fr/article/37462923", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jclp.23564" } }, { "@type": "ScholarlyArticle", "name": "Receipt of Behavioral Therapy in Preschool-Age Children with ADHD and Coexisting Conditions: A DBPNet Study.", "datePublished": "2023-09-26", "url": "https://questionsmedicales.fr/article/37751569", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/DBP.0000000000001216" } }, { "@type": "ScholarlyArticle", "name": "The role of psychological flexibility in acceptance-enhanced behavior therapy for trichotillomania: Moderation and mediation findings.", "datePublished": "2023-03-21", "url": "https://questionsmedicales.fr/article/37030243", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.brat.2023.104302" } }, { "@type": "ScholarlyArticle", "name": "Comparison of behavioral activation-enhanced cognitive processing therapy and cognitive processing therapy among U.S. service members: A randomized clinical trial.", "datePublished": "2023-07-04", "url": "https://questionsmedicales.fr/article/37418778", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.psychres.2023.115330" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009422" }, { "@type": "ListItem", "position": 3, "name": "Maladies neuromusculaires", "item": "https://questionsmedicales.fr/mesh/D009468" }, { "@type": "ListItem", "position": 4, "name": "Maladies musculaires", "item": "https://questionsmedicales.fr/mesh/D009135" }, { "@type": "ListItem", "position": 5, "name": "Myopathies congénitales structurales", "item": "https://questionsmedicales.fr/mesh/D020914" }, { "@type": "ListItem", "position": 6, "name": "Myopathie à axe central", "item": "https://questionsmedicales.fr/mesh/D020512" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Myopathie à axe central - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Myopathie à axe central", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Myopathie à axe central", "description": "Comment diagnostique-t-on la myopathie à axe central ?\nQuels tests génétiques sont utilisés ?\nQuels signes cliniques sont observés ?\nL'IRM est-elle utile pour le diagnostic ?\nQuel rôle joue l'historique familial ?", "url": "https://questionsmedicales.fr/mesh/D020512?mesh_terms=Behavior+Therapy&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Myopathie à axe central", "description": "Quels sont les principaux symptômes ?\nLa myopathie affecte-t-elle tous les muscles ?\nY a-t-il des symptômes respiratoires ?\nLes symptômes varient-ils selon l'âge ?\nDes troubles de la marche sont-ils fréquents ?", "url": "https://questionsmedicales.fr/mesh/D020512?mesh_terms=Behavior+Therapy&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Myopathie à axe central", "description": "Peut-on prévenir la myopathie à axe central ?\nLe dépistage est-il recommandé ?\nDes conseils de vie peuvent-ils aider ?\nLes activités physiques sont-elles bénéfiques ?\nLes consultations régulières sont-elles nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D020512?mesh_terms=Behavior+Therapy&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Myopathie à axe central", "description": "Quels traitements sont disponibles ?\nLes médicaments sont-ils efficaces ?\nLa chirurgie est-elle une option ?\nComment la rééducation aide-t-elle ?\nY a-t-il des traitements expérimentaux ?", "url": "https://questionsmedicales.fr/mesh/D020512?mesh_terms=Behavior+Therapy&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Myopathie à axe central", "description": "Quelles complications peuvent survenir ?\nLa myopathie peut-elle affecter la vie quotidienne ?\nY a-t-il un risque de cardiomyopathie ?\nLes infections sont-elles plus fréquentes ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D020512?mesh_terms=Behavior+Therapy&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Myopathie à axe central", "description": "Quels sont les facteurs de risque génétiques ?\nL'âge est-il un facteur de risque ?\nLe sexe influence-t-il le risque ?\nDes facteurs environnementaux jouent-ils un rôle ?\nLes maladies associées augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D020512?mesh_terms=Behavior+Therapy&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la myopathie à axe central ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique, l'électromyogramme et la biopsie musculaire." } }, { "@type": "Question", "name": "Quels tests génétiques sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques peuvent identifier des mutations dans le gène RYR1, associé à cette myopathie." } }, { "@type": "Question", "name": "Quels signes cliniques sont observés ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "On observe souvent une faiblesse musculaire proximale et des anomalies dans les biopsies musculaires." } }, { "@type": "Question", "name": "L'IRM est-elle utile pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'IRM peut montrer des anomalies musculaires caractéristiques de la myopathie à axe central." } }, { "@type": "Question", "name": "Quel rôle joue l'historique familial ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un historique familial de myopathies peut orienter le diagnostic vers une origine génétique." } }, { "@type": "Question", "name": "Quels sont les principaux symptômes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent faiblesse musculaire, fatigue et parfois des douleurs musculaires." } }, { "@type": "Question", "name": "La myopathie affecte-t-elle tous les muscles ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle touche principalement les muscles proximaux, comme ceux des hanches et des épaules." } }, { "@type": "Question", "name": "Y a-t-il des symptômes respiratoires ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, la faiblesse musculaire peut affecter les muscles respiratoires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent apparaître dès l'enfance ou à l'âge adulte, selon les cas." } }, { "@type": "Question", "name": "Des troubles de la marche sont-ils fréquents ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la faiblesse musculaire peut entraîner des difficultés à marcher ou à se lever." } }, { "@type": "Question", "name": "Peut-on prévenir la myopathie à axe central ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Étant génétique, il n'existe pas de prévention, mais un diagnostic précoce aide à la gestion." } }, { "@type": "Question", "name": "Le dépistage est-il recommandé ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le dépistage génétique peut être conseillé pour les familles à risque de transmission." } }, { "@type": "Question", "name": "Des conseils de vie peuvent-ils aider ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des conseils sur l'exercice et la nutrition peuvent améliorer la qualité de vie des patients." } }, { "@type": "Question", "name": "Les activités physiques sont-elles bénéfiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des activités adaptées peuvent aider à maintenir la force musculaire et la mobilité." } }, { "@type": "Question", "name": "Les consultations régulières sont-elles nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des suivis réguliers permettent d'ajuster les traitements et surveiller l'évolution." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement curatif, mais la physiothérapie aide à maintenir la force musculaire." } }, { "@type": "Question", "name": "Les médicaments sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour gérer les symptômes, mais leur efficacité varie." } }, { "@type": "Question", "name": "La chirurgie est-elle une option ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie n'est généralement pas indiquée, sauf pour des complications spécifiques." } }, { "@type": "Question", "name": "Comment la rééducation aide-t-elle ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La rééducation physique aide à améliorer la fonction musculaire et la qualité de vie." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des essais cliniques explorent des thérapies géniques et des traitements ciblés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des problèmes respiratoires et des déformations musculo-squelettiques." } }, { "@type": "Question", "name": "La myopathie peut-elle affecter la vie quotidienne ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la faiblesse musculaire peut limiter les activités quotidiennes et l'autonomie." } }, { "@type": "Question", "name": "Y a-t-il un risque de cardiomyopathie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines formes de myopathie peuvent être associées à des problèmes cardiaques." } }, { "@type": "Question", "name": "Les infections sont-elles plus fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les infections peuvent survenir en raison de la faiblesse musculaire et de l'immobilité." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une prise en charge multidisciplinaire est essentielle pour gérer les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque génétiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de myopathies augmentent le risque de développer cette maladie." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "L'âge d'apparition peut varier, mais les symptômes se manifestent souvent dans l'enfance." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les myopathies peuvent affecter les deux sexes, mais certaines formes sont plus fréquentes chez les hommes." } }, { "@type": "Question", "name": "Des facteurs environnementaux jouent-ils un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, les facteurs environnementaux ne sont pas clairement établis comme des risques." } }, { "@type": "Question", "name": "Les maladies associées augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies auto-immunes peuvent coexister avec la myopathie, mais leur lien n'est pas direct." } } ] } ] }

Sources (10000 au total)

Brief Behavioral Therapy for Anxiety and Depression in Pediatric Primary Care: Breadth of Intervention Impact.

To report on broad-based outcomes of the Brief Behavioral Therapy (BBT) trial for pediatric anxiety and depression. Secondary data analyses expand on previous reports by assessing diagnostic remission... Youth (N = 185; 8-16.9 years; 58% female; 78% White; 21% Hispanic) with anxiety and/or depression were eligible for this multi-site trial. Enrolled youth were randomly assigned to receive 8 to 12 sess... BBT was superior to ARC on remission of all targeted diagnoses (week 16: 56.8% vs 28.2%, p < .001; week 32: 62.5% vs 38.9%, p = .004), clinician-rated independent functioning (week 16: 75.0% vs 45.7%,... BBT has positive effects on youth, mediated by the strong impact of the intervention on anxiety. Analyses continue to support positive outcomes for Hispanic youth, suggesting that BBT is a broadly eff... Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care; https://clinicaltrials.gov; NCT01147614....

Drug use and suicidal ideation in the daily lives of individuals in a dialectical behavior therapy program.

Substance use disorders and borderline personality disorders (BPD) often co-occur and may be concurrently treated by Dialectical Behavior Therapy (DBT). However, there is limited information on how dr... This study examined the DBT diary cards of 47 individuals in a community mental health center's partial hospital and intensive outpatient program. Multilevel modeling techniques were used to examine t... Results indicated a significant relationship between same-day, 1-day lagged, 2-day lagged drug use and suicidal ideation. BPD was a moderator for the relationship between 1-day lagged drug use and sui... Limitations of the study include the measure for BPD symptom severity was only collected pretreatment and the results are likely limited to the effects of cannabis use on suicidal ideation. Clinicians...

Receipt of Behavioral Therapy in Preschool-Age Children with ADHD and Coexisting Conditions: A DBPNet Study.

Practice guidelines from the American Academy of Pediatrics and Society for Developmental and Behavioral Pediatrics recommend evidence-based behavioral therapy (BT) as first-line treatment for prescho... This retrospective medical record review was conducted across 7 Developmental Behavioral Pediatrics Research Network (DBPNet) sites. Data were abstracted for children <72 months old seen by a DBP clin... Of the 497 children in this study; 225 children (45%) had reported receipt of any BT prior to ADHD medication initiation, with 15.9% (n = 79) receiving PTBM. Children with co-existing diagnoses of ASD... The percentage of children with documented receipt of any BT, and particularly PTBM, was low across all sites and co-existing conditions. These findings highlight the universal need to increase receip...

Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts.

Generalized anxiety disorder (GAD) is common and disabling. Different versions of cognitive behavioral therapy (CBT) have been tested, but no treatment works for everyone. Therefore, researchers have ... The current narrative review examines meta-analyses and individual trials of CBT-based treatments for GAD. We focus on CBT and its cognitive and behavioral components as well as efforts to enhance CBT... We conclude that CBT is efficacious, and a number of enhancement efforts have shown some promise in improving upon CBT in single trials. However, more research is needed, particularly efforts to deter...

A 12-month study of dialectical behavioral therapy for bοrderline patients suffering from eating disorders.

Individuals with eating disorders (ED) and comorbid borderline personality disorder (BPD) may benefit from therapies focusing on emotion regulation, such as dialectical behavioral therapy (DBT). The a... Seventy-two BPD and ED (anorexia and bulimia nervosa) participants were recruited from the eating disorders unit of the 1st Psychiatric Department of National and Kapodistrian University of Athens. Al... The major finding of the study was the significant improvement of patients in all the outcome measurements after one year of treatment. The study's second finding was that the severity of BPD symptoma... These results support previous studies on the effectiveness of DBT for comorbid BPD and EDs. Despite the promising results, randomized controlled trials are needed to establish the efficacy of DBT for... Level IV: Evidence obtained from multiple time series with or without the intervention, such as case studies. Dramatic results in uncontrolled trials might also be regarded as this type of evidence....

Primary care provider uptake of intensive behavioral therapy for obesity in Medicare patients, 2013-2019.

The delivery of Intensive Behavioral Therapy (IBT) for obesity by primary care providers (PCPs) has been covered by Medicare to support elderly individuals with obesity (BMI > 30 kg/m2) in managing th... We used the Centers for Medicare and Medicaid Services Provider Utilization and Payment Data from 2013 to 2019 to identify all PCPs who served more than 10 Medicare beneficiaries in each of the seven-... Of the 537,754 eligible PCPs who served Medicare patients in any of the seven years, only 1.2% were found to be IBT service providers in at least one year from 2013 through 2019 (246 always users, 1,3... Very few PCPs continuously billed IBT services for Medicare patients with obesity. Further investigation is needed to mitigate barriers to the uptake of IBT services among PCPs....